WVP
SPRB

Worth Venture Partners’s Spruce Biosciences SPRB Stock Holding History

Worth Venture Partners’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,026
Closed -$1.54M – 127
2023
Q4 		$1.54M Buy
7,026
+2,998
+74% +$346K 0.83% 42
2023
Q3 		$683K Buy
4,028
+326
+9% +$54.9K 0.41% 67
2023
Q2 		$597K Buy
3,702
+94
+3% +$15.7K 0.33% 69
2023
Q1 		$581K Buy
+3,608
New +$670K 0.28% 78

Other funds holding SPRB

RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
SCM
Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Worth Venture Partners's SPRB Position: Q1 2024 in Review

Worth Venture Partners sold out of Spruce Biosciences (SPRB) in Q1 2024, closing a stake of 7,026 shares — an estimated $1.54M sold.

Worth Venture Partners first reported a position in SPRB in Q1 2023 and held it in 4 quarters. The position peaked at $1.54M in Q4 2023. 49 funds tracked by Wall St. Rank hold SPRB as of Q1 2024.

  • Worth Venture Partners reported no remaining Spruce Biosciences position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 7,026 Spruce Biosciences shares in Q1 2024, an estimated $1.54M.
  • Worth Venture Partners first reported a position in Spruce Biosciences in Q1 2023 and held it in 4 quarters.
  • Worth Venture Partners's Spruce Biosciences position peaked at $1.54M in Q4 2023.
  • 49 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.